Results for tag: "Solid Tumor Drug"

The Solid Tumor Drug market is a subset of the Oncology Drugs market, which focuses on the treatment of cancer. Solid Tumor Drugs are used to treat solid tumors, which are tumors that form a mass of abnormal cells. These drugs are used to reduce the size of the tumor, slow its growth, and reduce the spread of cancer cells. Solid Tumor Drugs can be administered orally, intravenously, or through injections. They can also be used in combination with other treatments such as radiation and chemotherapy. The Solid Tumor Drug market is highly competitive, with many companies offering a variety of treatments. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. Other companies in the market include AstraZeneca, Eli Lilly, Amgen, and Johnson & Johnson. Show Less Read more